Effects of systemic administration of mirtazapine on respiratory muscle activity in sleeping rats.

Mirtazapine (MIRT) is an antidepressant with mixed noradrenergic and serotonergic effects in central nervous system. The present study was undertaken to assess whether MIRT can stimulate genioglossus muscle (GG) activity in the conscious, behaving rat. Nine male rats were chronically instrumented with GG and neck muscle EMG electrodes. EEG electrodes were implanted to acquire sleep stage. Results demonstrated a dose-dependent effect of MIRT on GG activity during sleep, although no changes reached statistical significance. Low dose MIRT (0.1 mg/kg) showed a slight increase in GG phasic activity. In contrast, higher doses of MIRT (0.5-1.0 mg/kg) tended to decrease GG activity relative to vehicle, in addition to decreasing total sleep time.

Disinhibition of the dorsomedial hypothalamus increases the frequency of augmented breaths in the anesthetized rat.

The present study was undertaken to identify if activation of the dorsomedial hypothalamus (DMH) elicits augmented breaths (ABs). DMH disinhibition in urethane anesthetized rats produced both an increase in baseline respiratory rate (RR) and an increase in the number of ABs. The increase in RR was associated with a decrease in both the time of inspiration (T(i)) and expiration (T(e)) and the peak change in RR was observed 5 min post DMH activation. In contrast, the increase in ABs was greatest during the first 1.25 min, and both T(i)s of the ABs did not change significantly from pre-injection values. The T(e) of the ABs did decrease but remained significantly greater than the T(e) of the normal breath during DMH disinhibition. Our results support the hypothesis that the central neural pathway involved in the maintenance of normal respiratory pattern may be distinct from pathways involved in the generation of ABs.